Search by...
-
16JulThe EU Commission publishes an inquiry aiming at detecting possible competition concerns in the sector of the Internet of ThingsOn July 16, 2020 the European Commission (“Commission”) launched an inquiry into the sector of the Internet of Things for consumer-related products and services (“IoTs”) in the European Union pursuant to Article 17 of Regulation 1/2003. The inquiry is aimed at detecting possible competition concerns in the functioning of the IoTs markets and determining whether undertakings operating in such markets infringe EU competition rules. According to article 17, circumstances such as the level of trade between Member States and the rigidity of prices may suggest that a restriction or distortion of competition is occurring within the internal market.Article filed under: Concurrences, EU and Competition Law, Internet & Ecommerce, Privacy & Cyber Security
-
-
25JunSupply of personal protective equipment in the European Union – end of the authorization regimeIn response to the COVID-19 emergency, the Commission took measures to protect the availability of supplies of personal protective equipment, namely by adopting two Implementing Regulations, which required exports of such equipment outside of the European Union to be subject to an export authorization from Member States.
-
-
25JunImplementation of the registered exporter system: extension of the transition period until December 31, 2020Due to the COVID-19 emergency, Member States have the possibility to extend the transition period for the application of the registered exporter (REX) system until December 31, 2020.
-
-
25JunCyber Security & Litigation: practical tips on how to avoid a data breach and how to handle it - Part 1: Prevention is better than cureBy radically changing our working habits, the new coronavirus heightened existing protection needs to a whole new level of urgency.
-
-
19JunPatient Support Program in digitale, come farlo bene e a normaAnche in seguito all’emergenza, i Patient Support Program stanno trovando ampia diffusione. Ciò rende necessario un intervento normativo che guidi gli operatori del settore nello sviluppo dei programmi, soprattutto in caso di PSP digitali. Nel frattempo, il Codice Deontologico di Farmindustria può essere assunto come guida
-
-
12JunTrial clinici “a distanza”, un investimento a prova di futuroLe misure eccezionali messe in campo da Aifa durante l’emergenza fanno da apripista per nuovi modelli più efficienti. Dal monitoraggio centralizzato all’adozione di tecnologie per la source data verification, ecco gli strumenti cardine per spingere una completa digitalizzazione del processo
-
-
11JunMasks, disinfectants, and serological tests: regulatory issues relating to products to be used in phases 2 and 3 of the emergency periodAfter the lockdown, for correct management of phases 2 and 3, products such as masks and disinfectants become even more essential in containing and preventing the spread of COVID-19.
-
-
11JunVenture Capital watch: how COVID-19 is affecting and will affect VC transactions with a specific focus on the life sciences and healthcare sectorsThe COVID-19 outbreak is affecting VC transactions all over the world. Challenges but also opportunities may arise in sectors that will shape the post–COVID-19 world.
-
-
11JunAcquisitions of companies involved in the medical devices business fall under the Italian foreign investment controlMore than 2 months ago the Italian Government issued certain measures with the purpose of expanding its power to veto or impose conditions on acquisitions of, or other transactions involving, Italian targets operating in certain strategic sectors.
-
-
9JunDecreto Rilancio: overview of the main measures to support business and companies in ItalyGeneral overview of the additional measures set forth by Decreto Rilancio aimed at supporting Italian companies and businesses affected by the COVID-19 ongoing emergency.
-
